Hemas Holdings
Conglomerato sanitario e per la cura personale di Colombo con distribuzione farmaceutica regionale.
Hemas Holdings è un conglomerato dello Sri Lanka con divisioni sanitarie e di beni di consumo. Fondata nel 1948, la divisione FMCG produce prodotti per la cura personale (Baby Cheramy, Clogard) e la divisione sanitaria distribuisce prodotti farmaceutici nel sud e nel sud-est asiatico.
- Type
- brand seeking distribution
- Location
- Colombo, Sri Lanka
- Founded
- 1948
- Website
- hemas.com
- Categories
- Forniture medicali e sanitarie, Cura della persona
- Markets
- Bangladesh, Pakistan, Malaysia, Emirati Arabi Uniti
Verified facts
- corporate-mail-on-domain (green), checked 2026-08-08 Mail server of the company domain
- sanctions-clear (green), checked 2026-08-08 OpenSanctions
- debarment-clear (green), checked 2026-08-08 OpenSanctions
- domain-registered (green), checked 2026-08-08 Domain registry record
- lei-lapsed (amber), checked 2026-08-30 GLEIF global LEI register (golden copy)
Claimed certifications
- ISO 9001, Quality Management IAF CertSearch
- Good Manufacturing Practice
Import rules for these goods
- Cosmetic products must be notified in the EU Cosmetic Products Notification Portal (CPNP) before being placed on the EU market. European Commission (CPNP)
- For the US market, MoCRA requires cosmetic facility registration and product listing with the FDA. US FDA (MoCRA)
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)